These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 10181877)
1. Final chapter inked in IHC saga. Graziano C CAP Today; 1998 Jul; 12(7):1, 28, 32. PubMed ID: 10181877 [No Abstract] [Full Text] [Related]
2. Disclaimer now needed for analyte-specific reagents. Graziano C CAP Today; 1998 Nov; 12(11):5, 8, 11. PubMed ID: 10339306 [No Abstract] [Full Text] [Related]
3. Withdrawal of a drug from the market: what should the prescriber do? Ross-Degnan D; Soumerai SB; Fortess EE; Gurwitz JH JAMA; 1994 Oct; 272(16):1253. PubMed ID: 7933365 [No Abstract] [Full Text] [Related]
4. Off-label use of prescription drugs. Hill M Dermatol Nurs; 2000 Aug; 12(4):238, 256. PubMed ID: 11912659 [No Abstract] [Full Text] [Related]
5. Off-label drug use. Dooley AG Med Health R I; 2007 Feb; 90(2):63-5. PubMed ID: 17500258 [No Abstract] [Full Text] [Related]
6. Use of approved drugs for unlabeled indications. Stratton WT Kans Med; 1993 Nov; 94(11):286. PubMed ID: 8309159 [No Abstract] [Full Text] [Related]
7. Stoning a dead bird: advertising limits on approved new drugs. Strobos J Food Drug Law J; 1995; 50(4):533-51. PubMed ID: 10343018 [No Abstract] [Full Text] [Related]
8. Pro: The Food and Drug Administration Black box warning on droperidol is not justified. Habib AS; Gan TJ Anesth Analg; 2008 May; 106(5):1414-7. PubMed ID: 18420854 [No Abstract] [Full Text] [Related]
9. Pharmaceutical innovation and mortality in the United States, 1960-2000. A commentary on Schnittker and Karandinos. Lichtenberg F Soc Sci Med; 2010 Apr; 70(7):969-71; discussion 974-5. PubMed ID: 20167408 [No Abstract] [Full Text] [Related]
13. Industry view on the regulation of ancillary reagents. Schifreen RS; Louth C Food Drug Law J; 1996; 51(1):155-9. PubMed ID: 11794348 [No Abstract] [Full Text] [Related]
14. Be wary of recommending off-label use of meds. Luttrull S Adv Nurse Pract; 2001 Feb; 9(2):18. PubMed ID: 12416047 [No Abstract] [Full Text] [Related]
15. FDA response to droperidol black box warning editorials. Rappaport BA Anesth Analg; 2008 May; 106(5):1585. PubMed ID: 18420886 [No Abstract] [Full Text] [Related]
16. [Studies on administration of in-vitro diagnostic reagents]. Wang Z; Qian H; Xu FL; Huang JH; Gu WK Zhongguo Yi Liao Qi Xie Za Zhi; 2005 Mar; 29(2):124-30. PubMed ID: 16011119 [TBL] [Abstract][Full Text] [Related]
17. Off-label or off-limits? Ratner M; Gura T Nat Biotechnol; 2008 Aug; 26(8):867-75. PubMed ID: 18688236 [No Abstract] [Full Text] [Related]
18. Has the food and drug administration changed the drug approval process? Somberg JC Am J Ther; 2011 May; 18(3):179. PubMed ID: 21566467 [No Abstract] [Full Text] [Related]
19. FDA guidance on antimicrobials aims to prevent resistance. O'Rourke K J Am Vet Med Assoc; 2003 Dec; 223(12):1714-5, 1719. PubMed ID: 14690196 [No Abstract] [Full Text] [Related]
20. Extralabel use of nonsteroidal anti-inflammatory drugs. Damian P; Craigmill AL; Riviere JE J Am Vet Med Assoc; 1997 Oct; 211(7):860-1. PubMed ID: 9333086 [No Abstract] [Full Text] [Related] [Next] [New Search]